Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accuracy, aforementioned, Alaska, amlodipine, appointed, arising, attached, attendant, Auerbach, backdated, benazepril, calendar, caption, Chairman, communicated, compensatory, copy, covenant, coverage, cumulative, dealing, deemed, default, essence, event, exceed, factual, failure, faith, furnished, GAAP, good, Hariharan, inappropriate, incorporated, incorporation, indenture, individually, installment, irrespective, issuer, language, lease, LePore, merit, Michael, Middle, monetary, nominal, Patrick, prejudgment, preserving, prudent, purportedly, question, receipt, reissuance, relationship, remediation, renewal, Scientific, Shankar, solicit, Southern, stay, Supreme, theRoxanelawsuit, tracing, trustee, unjustly, unpaid, Unregistered, unremedied, upheld, venture, verified, Vice, Western, whichever
Removed:
Abbott, accused, Conflict, contractual, convert, dismissal, Endo, fenofibrate, fiscal, forum, Fournier, galantamine, Holding, hydrobromide, Industrie, Institute, obligation, ownership, plc, Prevention, recently, reduce, reduction, represent, request, retaining, Sante, sharing, specific, sue, Synaptech, TriCor
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 Employment Agreement by & Between Par Pharmaceutical Companies and Patrick Lepore
- 10.2 Separation Agreement by & Between Par Pharmaceuticals & Mark Auerbach
- 10.3 Separation Agreement by & Between Par Pharmaceuticals & Michael Graves
- 10.4 Separation Agreement by & Between Par Pharmaceuticals & Shankar Hariharan
- 31.1 Certification of the Principal Executive Officer
- 31.2 Certification of the Principal Financial Officer
- 32.1 Certification by the Chief Executive Officer
- 32.2 Certification by the Chief Financial Officer
Related press release
PRX similar filings
Filing view
External links
Exhibit 31.2
Certification Pursuant to Rule 13a-14(a) of the Exchange Act
This certification will be provided when the registrant completes its restatement of certain financial statements and an evaluation of its disclosure controls and procedures and internal control over financial reporting and amends this Form 10-Q to include the financial and information required by Part I, Items 1 and 2. Please see the registrant’s Notification of Late Filing on Form 12b-25/A filed with the Commission as of the date hereof for more details.